Ertapenem Pharmacokinetics in Equine Plasma and Synovial Fluid After Administration via Continuous Rate Infusion
This study describes the pharmacokinetics of ertapenem as a continuous rate infusion (CRI) administered to horses at a rate of 3.75 mg/kg/h. Blood (30, 60, 120, 360, 480 min) and synovial (60, 120, 240, 360 min) samples were collected throughout the 8‐hour infusion. Pharmacokinetic analysis was performed with noncompartmental methods. Parameters calculated included partial area under the curve (AUC), maximum concentration ( C max ), and clearance (CL). In plasma, the C max was 47.10 μg/mL (CV = 21.69%) and CL was 97.86 mL/kg/h (CV 17.83%). In synovial fluid, the C max was 25.71 μg/mL (CV 33.49%). The ratio of the synovial fluid to plasma concentration of ertapenem was 35.86% (CV 14.7%) and 54.58% (CV 22%) for AUC and C max , respectively. These values represent the extent of penetration from the plasma to synovial fluid. Ertapenem was well tolerated, although it caused transient soft feces in three horses. Ertapenem use in horses should be reserved for cases where culture and susceptibility results support administration and the isolated bacteria are not susceptible to other antimicrobials. Administration via continuous rate infusion is convenient for intensive care facilities and extended orthopedic surgery cases in reducing development of resistance by decreasing the total time below MIC and total drug administered.
Authors
- Mark G. Papich (ORCID: https://orcid.org/0000-0002-7591-7898)
- James A. Orsini (ORCID: https://orcid.org/0009-0000-5358-6568)
- Alexa R. Bish‐Jones (ORCID: https://orcid.org/0009-0009-8527-1320)
Institutions
- North Carolina State University (US)
- University of Georgia (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Veterinary Pharmacology and Therapeutics
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1111/jvp.70122
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00